Abstract

We attempted to detect, for the first time in a Brazilian cohort, differences in protein expression between clear-cell renal cell carcinoma (ccRCC) and their normal adjacent tissues, aiming to identify biomarkers and/or therapeutic target candidates for this disease. Twenty-four ccRCC and adjacent normal tissues were collected after surgery and their protein extracts were quantified, pooled and separated by two-dimensional polyacrylamide gel electrophoresis (2DE), followed by statistical analysis of the stained gels. Spots of interest were excised from the gels, digested with trypsin and identified by MALDI-TOF-TOF mass spectrometry. Twenty-six differential spots were detected between the two classes of tissues, among which twenty were identified by mass spectrometry and sixteen were found to be non-redundant. Eleven proteins were either underexpressed or undetected in the ccRCC extracts, such as prohibitin and peroxiredoxin-3, whereas five were found to be overexpressed or exclusively detected in the ccRCC extract, including αβ crystalin and heat shock protein 27. Several proteins were detected at differential levels when compared to normal adjacent tissues, and, moreover, many have been previously described by their relationship with RCC. Therefore, this work corroborates previous reports on the search for biomarkers for ccRCC, as well as it points out new candidates that may be validated in future studies.

Highlights

  • Renal cell carcinoma (RCC) is the third most common cancer of the genitourinary system and represents approximately 3% of adult malignancies in Western countries

  • This study aimed to identify differentially expressed proteins in clear-cell renal cell carcinoma (ccRCC) tissues compared to their adjacent normal kidney tissues in 2DE gels

  • We found underexpression of prohibitin in ccRCC extracts, which is consistent with its apparent tumor suppressor function and free radical protection

Read more

Summary

Introduction

Renal cell carcinoma (RCC) is the third most common cancer of the genitourinary system and represents approximately 3% of adult malignancies in Western countries. It is the most prevalent malignancy of the kidney, accounting for about 85% of kidney cancers, as well as the most lethal of all urologic cancers. The most common histological subtype is the clear-cell renal cell carcinoma (ccRCC), corresponding to 70% of all RCC [1]. Cancer markers can be used for early detection of disease in asymptomatic patients, for the assessment and management of the disease in its ibju | Differencial proteome of clear-cell renal cell carcinoma different phases, as well as for predicting its prognosis. None of them achieved definitive diagnostic and prognostic value in clinical practice so far

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call